top of page
it's where dermatology lives
1/2
Baricitinib shows promise in alopecia areata
The results of two phase 3 trials of patients with severe alopecia areata (AA) indicate that oral baricitinib was superior to placebo...
Allan Ryan
Mar 28, 20222 min read
New oral JAK inhibitor effective for moderate-to-severe AD
Recently published findings from clinical trials of the oral Janus kinase (JAK) inhibitor upadacitinib show it is highly effective in...
John Evans
May 21, 20212 min read
Featured Posts
bottom of page